1. Home
  2. VFF vs MREO Comparison

VFF vs MREO Comparison

Compare VFF & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$3.53

Market Cap

396.2M

Sector

N/A

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.56

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
MREO
Founded
1989
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.2M
324.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VFF
MREO
Price
$3.53
$0.56
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
N/A
$3.90
AVG Volume (30 Days)
1.6M
37.8M
Earning Date
03-12-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
$351,979,000.00
$500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.25
$6,363.05
P/E Ratio
$18.79
N/A
Revenue Growth
56.61
N/A
52 Week Low
$0.45
$0.20
52 Week High
$4.99
$3.26

Technical Indicators

Market Signals
Indicator
VFF
MREO
Relative Strength Index (RSI) 49.02 33.56
Support Level $3.26 $0.51
Resistance Level $3.65 $0.78
Average True Range (ATR) 0.16 0.10
MACD -0.01 0.03
Stochastic Oscillator 57.14 49.17

Price Performance

Historical Comparison
VFF
MREO

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: